[1] ARAN V, VICTORINO A P, THULER L C, et al. Colorectal cancer:Epidemiology, disease mechanisms and interventions to reduce onset and mortality[J]. Clin Colorectal Cancer, 2016, 15(3):195-203. [2] GONZÁLEZ N, PRIETO I, DEL PUERTO-NEVADO L, et al. 2017 update on the relationship between diabetes and colorectal cancer:epidemiology, potential molecular mechanisms and therapeutic implications[J]. Oncotarget, 2017, 8(11):18456. [3] LIAO Y H, XIA N, ZHOU S F,et al. Interleukin-17A contributes to myocardial ischemia/reperfusion injury by regulating cardiomyocyte apoptosis and neutrophil infiltration[J]. Life Sci, 2016, 149(4):10-17. [4] GRASER A, EKICI A B, SOPEL N, et al. Rhinovirus inhibits IL-17A and the downstream immune responses in allergic asthma[J]. Mucosal Immunol, 2016, 9(5):1183-1192. [5] ZHAO W M, SHAYIMU P, LIU L, et al. Association between IL-17A and IL-17F gene polymorphisms and risk of gastric cancer in a Chinese population[J]. Genet mol Res, 2016, 15(3).DOI:10.4238/gmr.15037864. [6] CHOI W S, KIM O, YOON J H, et al. Association of IL-17A/Fpolymorphisms with the risk of gastritis and gastric cancer in the Korean population[J]. Mol Cell Toxicol, 2016, 12(3):327-336. [7] 王庆生, 陆航, 陈汉蕊,等. IL-17A通过NF-κB通路介导MMP-2/9表达促进结肠癌SW480细胞迁移和侵袭[J]. 中国肿瘤生物治疗杂志, 2017, 24(5):516-520. [8] BHAT S, GARDI N, HAKE S, et al. Impact of intra-tumoral IL17A and IL32 gene expression on T-cell responses and lymph node status in breast cancer patients[J]. J Cancer Res Clin Oncol,2017,143(9):1745-1756. [9] 张蓉, 梅红, 聂亚红,等. Th17细胞及IL-17在卵巢癌患者外周血中的表达及临床意义[J]. 中国实验诊断学, 2016, 20(7):1103-1105. [10] KIM B, PARK B. Saffron carotenoids inhibit STAT3 activation and promote apoptotic progression in IL-6-stimulated liver cancer cells[J]. Oncol Rep, 2018,39(4):1883-1891. [11] CHEN S F, ZHANG Z Y, ZHANG J L. Matrine increases the inhibitory effects of afatinib on H1975 cells via the IL-6/JAK1/STAT3 signaling pathway[J]. Mol Med Rep, 2017,16(3):2733-2739. [12] WEI L L, XIONG H F,LI W, et al. Upregulation of IL-6 expression in human salivary gland cell line by IL-17 via activation of p38 MAPK, ERK, PI3K/Akt, and NF-κB pathways[J]. J Oral Pathol Med,2018,47(9):847-855. [13] WU J H, GUO J P, CAO Q, et al.Autophagy impacts on oxaliplatin-induced hepatocarcinoma apoptosis via the IL-17/IL-17R-JAK2/STAT3 signaling pathway[J]. Oncol Lett,2017,3(2):770-776. [14] 马松林, 张姮, 廖宇圣,等. Wnt3a对结肠癌SW480细胞增殖的影响及作用机制[J]. 山东医药, 2016, 56(37):23-25. [15] 冯洁琼, 冯梅宝, 徐芳英. 炎症小体与结直肠癌的研究进展[J]. 中华病理学杂志, 2017, 46(2):132-135. [16] 李必一, 王若雨, 赵勇. IL-17在肿瘤发生发展中的作用及其临床意义[J]. 中国医药生物技术, 2016, 12(1):64-68. [17] 赵子龙, 周国江, 任玉峰,等. IL-1β、IL-6、IL-17的表达和HPV感染与宫颈癌的相关性研究[J]. 实用癌症杂志, 2017, 32(3):358-360. [18] 杨丽娟, 赵莎, 张海谱,等. IL-17体内外抗肿瘤作用及其机制研究[J]. 免疫学杂志, 2012,28(9):764-769,775. [19] 魏泰, 吴立玲, 俞光岩. 白介素-17在恶性肿瘤发生发展过程中作用及其机制的研究进展[J]. 生理科学进展, 2016,47(5):335-339. [20] 郑仁东, 张会峰, 曹琳,等. 白细胞介素6对未分化型甲状腺癌肿瘤干细胞增殖的影响[J]. 中华内分泌代谢杂志, 2016, 32(10):851-856. [21] 曹洪, 罗洁, 刘国文,等. 姜黄素抑制STAT3磷酸化对乳腺癌细胞增殖及Hsp90α表达的影响[J]. 临床与实验病理学杂志, 2016, 32(5):510-513. [22] 焦政, 朱国琴, 周逸婵,等. 熊果酸通过AMPK/STAT3/COX-2信号通路抑制胃癌细胞增殖[J]. 胃肠病学, 2017, 22(4):208-213. [23] 王五艺, 程勇, 万林. AGEs通过JAK2/STAT3信号通路诱导结肠癌SW480细胞增殖、侵袭及上皮间质转化[J]. 第三军医大学学报, 2017,39(24):2390-2395. [24] 李可心,臧梦雅,王冬梅,等.IL-17A对肝癌细胞系干性的影响[J].临床肝胆病杂志,2017,33(6):1131-1136. [25] 杨学良,孙雪梅,赵晓晖,等.IL-17E和IL-17F及其受体在结直肠癌组织中的表达及其意义[J].吉林大学学报:医学版,2018,44(3):574-578. [26] WU X, YANG T, LIU X, et al. IL-17 promotes tumor angiogenesis through Stat3 pathway mediated upregulation of VEGF in gastric cancer[J]. Tumor Biol, 2016, 37(4):1-9. [27] HUANG Q, HAN J, FAN J, et al. IL-17 induces EMT via Stat3 in lung adenocarcinoma[J]. Am J Cancer Res, 2016, 6(2):440-451. |